about
Identification of human activin and TGF beta type I receptors that form heteromeric kinase complexes with type II receptorsType I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor beta and activinHuman type II receptor for bone morphogenic proteins (BMPs): extension of the two-kinase receptor model to the BMPsp38 MAPK Signaling in Osteoblast DifferentiationMicroRNAs and post-transcriptional regulation of skeletal developmentThe p38/MK2/Hsp25 pathway is required for BMP-2-induced cell migrationMolecular cloning, expression, and chromosomal localization of a ubiquitously expressed human 6-phosphofructo-2-kinase/ fructose-2, 6-bisphosphatase gene (PFKFB3)Regulation of ubiquitous 6-phosphofructo-2-kinase by the ubiquitin-proteasome proteolytic pathway during myogenic C2C12 cell differentiationThe human ubiquitous 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase gene (PFKFB3): promoter characterization and genomic structureProgestins activate 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (PFKFB3) in breast cancer cells6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase expression in rat brain during developmentMyogenin protein stability is decreased by BMP-2 through a mechanism implicating Id1Filamin B plays a key role in vascular endothelial growth factor-induced endothelial cell motility through its interaction with Rac-1 and Vav-2.Glycogen synthase kinase-3β is involved in ligand-dependent activation of transcription and cellular localization of the glucocorticoid receptor.The p38α MAPK function in osteoprecursors is required for bone formation and bone homeostasis in adult miceThe human HERC3 gene maps to chromosome 4q21 by fluorescence in situ hybridization.The giant protein HERC1 is recruited to aluminum fluoride-induced actin-rich surface protrusions in HeLa cells.PFKFB3 activation in cancer cells by the p38/MK2 pathway in response to stress stimuli.Requirement of phosphatidylinositol-4,5-bisphosphate for HERC1-mediated guanine nucleotide release from ARF proteins.Repression of SOX6 transcriptional activity by SUMO modification.Contribution of S6K1/MAPK signaling pathways in the response to oxidative stress: activation of RSK and MSK by hydrogen peroxideTherapeutic ultrasound stimulates MC3T3-E1 cell proliferation through the activation of NF-κB1, p38α, and mTOR.Clinical Utility Gene Card for: Fibrodysplasia ossificans progressiva.Extracellular calcium promotes bone formation from bone marrow mesenchymal stem cells by amplifying the effects of BMP-2 on SMAD signallingCharacterization and cloning of a receptor for BMP-2 and BMP-4 from NIH 3T3 cells.Cloning and expression of a catalytic core bovine brain 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase.BMP signaling in telencephalic neural cell specification and maturation.Tris-acetate polyacrylamide gradient gel electrophoresis for the analysis of protein oligomerization.The E3 ubiquitin protein ligase HERC2 modulates the activity of tumor protein p53 by regulating its oligomerizationCapsaicin modulates proliferation, migration, and activation of hepatic stellate cells.MicroRNA-322 (miR-322) and its target protein Tob2 modulate Osterix (Osx) mRNA stability.Osterix induces Col1a1 gene expression through binding to Sp1 sites in the bone enhancer and proximal promoter regions.Sertoli-secreted FGF-2 induces PFKFB4 isozyme expression in mouse spermatogenic cells by activation of the MEK/ERK/CREB pathway.Noncanonical BMP signaling regulates cyclooxygenase-2 transcription.Conserved regulatory motifs in osteogenic gene promoters integrate cooperative effects of canonical Wnt and BMP pathways.p38 regulates expression of osteoblast-specific genes by phosphorylation of osterixSimultaneous electrophoretic analysis of proteins of very high and low molecular mass using Tris-acetate polyacrylamide gels.Akt-dependent activation of the heart 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFKFB2) isoenzyme by amino acids.Class I PI-3-Kinase Signaling Is Critical for Bone Formation Through Regulation of SMAD1 Activity in Osteoblasts.BMP-2 decreases Mash1 stability by increasing Id1 expression.
P50
Q24319747-7452CC8C-5CD1-4CD4-B955-549E126401E7Q24612297-92CE6042-7598-4EDF-B2F9-D0BBD3FA6AC8Q24651958-681E5802-7409-482A-8F05-B2F200F7E956Q26747239-1E3F9D88-C97B-46F7-99C0-0E07A23809EDQ26863211-58A2582C-A758-41FC-9371-FBF9445C223AQ27437628-EDC185D7-1789-4E58-85C5-77A9550512D0Q28138539-C20E3596-E3F0-4343-B8EA-15371ADEF5F4Q28203231-C4B0AFB9-CDC4-4729-94C5-15F6932E28ECQ28204596-48A7080E-C097-4B8D-9F05-E76B3C5F1FEBQ28253893-75FB2135-AC93-4A7B-8911-170CE3D53F2CQ28574513-2F123514-787C-438F-82C1-DD8C7C253A82Q28590361-704CA54A-5917-4A71-AD70-1DD1F6AA1986Q30494138-F4FA2570-CDD7-4287-92B2-6BDCBE681E1AQ33636330-4B6F247A-D603-45C0-805D-048C6C7676D2Q33875419-3381C205-04CE-47AD-8C3D-33CFCF48F7AAQ33892245-FCF62FBF-B3DA-4C1B-9841-E14E068E8FE0Q34298308-F81FA21E-26AB-47E3-8105-49A5AF2DC58BQ34336533-F7C97E28-DD39-48CF-8AF7-BDE55371B54FQ34383208-B1FD67BB-0570-4144-936E-470C6234C14DQ34489010-BA858B6E-B9D6-4436-AFF3-D41DA17BB86FQ34995113-9169AA02-07E7-4D3F-8B6E-0765135D7AA9Q35790571-A424A246-3CF9-43DB-A32A-A82156702EAFQ36116661-C4F81372-6F6C-40E2-ABE9-5F8FF5752859Q36380663-614ACE6A-75C9-43DF-A3AB-51D6BDF9BB26Q36665327-29745755-7141-4E96-8A3B-46582BAEFF7CQ36702199-FD66D527-24E7-44BA-A8EE-AD2C3B24915AQ38114048-81329689-6634-4700-BBB1-C4D3BCFA9F5BQ38804776-25173C68-CEA7-4C45-9696-B6E1674A07C2Q39005319-216997AB-2E54-43B3-8485-754EDFADF24CQ39108646-D96B4154-2F5E-4E12-87F5-D066FD115A09Q39169811-DC3157C7-F6D2-4D16-BA5D-1C52EEA27576Q39243354-3D802153-901B-47D1-9EB5-C962246D6993Q39312108-8888115F-A551-4E94-8FD5-E4DAC27F3836Q39570977-1C9BE351-70ED-44F1-94A2-AEB451E6E1BFQ39650219-5F4E8874-224B-4FD0-900F-326F9C831DA8Q39671916-0230DD80-478C-4ACD-8601-3C102AC27230Q39724425-9AC3BEC1-BEEF-40DA-B553-43B88CEDC10EQ39795284-236B7873-DB8A-4052-9FBD-82E1D108EA87Q39982671-A74B4389-239E-4831-B99E-56AA9AA93E51Q39996530-FCAF1E36-5A87-479C-AA73-9364A4083897
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Francesc Ventura
@ast
Francesc Ventura
@en
Francesc Ventura
@es
Francesc Ventura
@nl
Francesc Ventura
@sl
type
label
Francesc Ventura
@ast
Francesc Ventura
@en
Francesc Ventura
@es
Francesc Ventura
@nl
Francesc Ventura
@sl
prefLabel
Francesc Ventura
@ast
Francesc Ventura
@en
Francesc Ventura
@es
Francesc Ventura
@nl
Francesc Ventura
@sl
P1053
K-9700-2014
P106
P21
P31
P3829
P496
0000-0001-9673-9405